Chemoinformaics analysis of Tetraethyl silicate
| Molecular Weight | 208.33 | nRot | 8 |
| Heavy Atom Molecular Weight | 188.17 | nRig | 0 |
| Exact Molecular Weight | 208.113 | nRing | 0 |
| Solubility: LogS | -1.785 | nHRing | 0 |
| Solubility: LogP | 1.97 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 35.4339 |
| nHD | 0 | BPOL | 42.4481 |
| QED | 0.567 |
| Synth | 2.836 |
| Natural Product Likeliness | -0.069 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.022 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.158 |
| MDCK | 0.0000362 |
| BBB | 0.069 |
| PPB | 0.541756 |
| VDSS | 1.185 |
| FU | 0.321925 |
| CYP1A2-inh | 0.223 |
| CYP1A2-sub | 0.72 |
| CYP2c19-inh | 0.154 |
| CYP2c19-sub | 0.862 |
| CYP2c9-inh | 0.026 |
| CYP2c9-sub | 0.915 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.73 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.106 |
| CL | 7.634 |
| T12 | 0.587 |
| hERG | 0.125 |
| Ames | 0.265 |
| ROA | 0.001 |
| SkinSen | 0.111 |
| Carcinogencity | 0.318 |
| EI | 0.902 |
| Respiratory | 0.004 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.844863 |